Pharma and the Covid19 Crisis – An Interaction with Sunil Attavar, CMD, Group Pharma

This is the first part of MedicinMan interview series with pharma business leaders to make sense of the Covid19 crisis and its impact on healthcare industry. Subscribe to MedicinMan to get regular updates of interactions with pharma business leaders.

MedicinMan: Give our readers, a sense of what is happening in the pharma industry since the corona virus outbreak. What are the main areas of impact? How are Indian Pharma leaders responding to these challenges and what are the timelines that they are looking at in terms of the current situation?